The investigators are doing this study to find out if a new kind of breast imaging (called upright dedicated breast CT or UBCT) can help doctors to see the small structures in breast tissue more clearly in 3-D and without overlap.
The breast imaging device that will be used in this study (UBCT) is not FDA-approved, so this is a research study. The machine has been designed to remove mammography-like breast compression and use radiation dose comparable to mammography. The breast CT device will take multiple x-ray pictures of the subjects breast in approximately 20 seconds and create a 3-D image of the breast. It does not compress or squish the breast like a mammogram.
(1) who were 40 years of age or older (typical screening age range), and,
(2) who were asymptomatic, and,
(3) who underwent or scheduled to undergo a standard-of-care 2-view bilateral digital breast tomosynthesis screening exam.
(1) who were 40 years of age or older, and,
Males
Women less than 40 years old
pregnant or lactating women
women with physical limitations (e.g., kyphosis) that may prohibit UBCT exam
Parallel
Low dose, upright, dedicated breast CT
DeviceThis study investigates the feasibility of an upright, dedicated breast CT (UBCT) for breast cancer detection.
Feasibility of UBCT
The proportion of participants who successfully complete the imaging exam using upright, dedicated breast CT (UBCT).
Click on the lead sponsor to view all of their trials.
University of Arizona
Lead sponsor
National Cancer Institute (NCI)
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
